News
-
Aptar Pharma has announced the launch of its new eDose counter for MDIs at RDD 2016. According to the company, the eDose counter can be used with any metering valve; the counter’s sensor detects the… Read more . . .
-
GlaxoSmithKline has opened a new £56 million, 4500 m2 manufacturing facility for its Ellipta DPI products. According to GSK, the new facility will create 150 jobs and will double production of Ellipta inhalers at the… Read more . . .
-
Discovery Laboratories, which is developing Aerosurf aerosolized KL4 surfactant for the treatment of respiratory distress syndrome in premature infants, has changed its name to Windtree Therapeutics, the company said. CEO Craig Fraser, who was appointed… Read more . . .
-
Swedish CDMO Recipharm has announced that it will acquire Kemwell’s CDMO business, including North Carolina-based Cirrus Pharmaceuticals. Kemwell acquired Cirrus Pharmaceuticals, which offers OINDP development and manufacturing services, in 2013. In February 2016, Cirrus Pharmaceuticals… Read more . . .
-
The Medicon Valley Inhalation Consortium (MVIC) has announced the appointment of Lars Asking as VP as of May 1, 2016. Asking was most recently Principle Scientist at Novo Nordisk and previously developed inhaled products at… Read more . . .
-
Powder characterization specialist Freeman Technology has announced that its Chinese operations have moved into a larger facility equipped with a laboratory and that the company has hired Tom Qin as General Manager and Ruty Li… Read more . . .
-
Mast Therapeutics has announced that the Duke Clinical Research Institute will serve as the coordinating center for the Heart Failure Clinical Research Network (HFN) as it conducts a Phase 2 study of AIR001 sodium nitrite… Read more . . .
-
Quotient Clinical’s new GMP facility in Nottingham, UK will include added spray drying capacity for spray drying of batches up to 2 kilograms. The facility is scheduled to open later this year. Quotient Clinical’s inhaled… Read more . . .
-
Hovione has announced the launch of a new company called Hovione Technology, which “focuses on offering an inhaler that matches your product, your needs, your patients.” The company’s devices include the Twin Caps and PowdAir… Read more . . .
-
Raptor Pharmaceutical has launched Quinsair levofloxacin inhalation solution for the treatment of P. aeruginosa infections in cystic fibrosis patients in Germany and Denmark, the company said. According to Raptor, it plans to launch Quinsair in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.